| Literature DB >> 28056057 |
Yimin Zhong1, Xinxing Guo1, Hui Xiao1, Jingyi Luo1, Chengguo Zuo1, Xiaobo Huang1, Jingjing Huang1, Lan Mi1, Qingjiong Zhang1, Xing Liu1.
Abstract
PURPOSE: Trabeculectomy has been regarded as a mainstay of initial treatment in eyes of angle closure glaucoma (ACG) with peripheral anterior synechia > 180° in the Chinese population while its efficacy in secondary ACG with BEST1 gene mutation remains unclear. We set out to investigate the treatment outcome of trabeculectomy for secondary ACG in a group of patients with autosomal recessive bestrophinopathy (ARB).Entities:
Mesh:
Substances:
Year: 2017 PMID: 28056057 PMCID: PMC5215797 DOI: 10.1371/journal.pone.0169395
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Anterior segment photograph and UBM images of a 46-year-old female patient.
(1A, 1B) Photograph and UBM showed relatively shallow anterior chamber of the right eye. (1C) Color photograph showed flat anterior chamber and moderately dilated pupil of the left eye. (1D) UBM findings showed flat anterior chamber (nearly corneo-lenticular touch) in the left eye one month after trabeculectomy.
Fig 2Images of a 22-year-old male patient.
(2A) Fundus photograph demonstrating increased cup-to-disc ratio, RPE irregularities in the macula and the surrounding retina, with yellow-white subretinal deposits (black arrows). No obvious macular edema was observed. (2B) FFA showing punctuate or patched hyperfluorescence in the macula and the posterior retina. (2C) ICGA showing markedly dilated choroidal vessels in the posterior pole.
Fig 3OCT images of a 23-year-old female patiento.
OCT images of right and left eyes showing thinning of the retinal nerve fiber layer, diffused serous neuroretinal detachment, parafoveal intraretinal fluid collections, hyperreflective subretinal accumulations (blue arrows), elongated and thickened photoreceptor outer segment layer.
BEST1 mutations identified in the patients.
| Patient | Age at onset | Mutation | Protein Effect | SIFT | Polyphen-2 | Reported or not |
|---|---|---|---|---|---|---|
| 1 | 13 | c.38G>A/c.763C>T | p.R13H/p.R255W | T/D | B/PrD | Reported/reported |
| 2 | 29 | c.763C>T/c.763C>T | p.R255W/p.R255W | D/D | PrD/PrD | Reported |
| 3 | 21 | c.389G>T/c.488T>G | p.R130L/p.M163R | D/D | PrD/PrD | Reported/reported |
| 4 | 19 | c.842T>C/c.247+2T>G | p.F281S/Splicing defect | D/ NA | PrD/ NA | Novel/novel |
| 5 | 38 | c.1070C>T/c.1550C>G | p.A357V/p.S517* | D/NA | B/NA | Novel/novel |
| 6 | 25 | c.764G>A/c.830C>T | p.R255Q/p.T277M | T/D | PrD/PrD | Novel/reported |
| 7 | 35 | c.1066C>T/ c.1066C>T | p.R356* /p.R356* | NA/ NA | NA/ NA | Reported |
| 8 | 33 | c.764G>A/c.763C>T | p.R255Q/p.R255W | D/D | PrD/PrD | Novel/reported |
T, Tolerated; D, Damaging; PrD, Probably damaging; B, Benign; NA, No applicable for variants other than amino acid substitution.